Tenderwize
Wróć do wyszukiwania

Pharmaceutical Products – Clindamycin + Benzoylperoxide

BARMER Beschaffung und Vergabe·Wuppertal, Germany·Deadline May 01, 2028 · 613 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisać
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Arzneimittelrabattverträge mit Beitrittsoption

50/100

Ocena szansy

Needs reviewLow complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

50 / 100

Złożoność

30 / 100

Czynniki ryzyka

The notice explicitly states it is not a public procurement under EU directives. This may limit suppliers' legal recour...

No estimated value or budget provided. Unknown volume or pricing expectations could lead to wasted effort or unprofitab...

No procurement documents available

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2028
  • Supply of pharmaceutical product with active ingredient Clindamycin + Benzoylperoxide
  • Framework agreement with option for additional parties to join
Pokaż pełne podsumowanie

This is a voluntary publication for a framework agreement (with option to join) for the supply of pharmaceutical products containing Clindamycin and Benzoylperoxide. The buyer is BARMER, a German health insurance company. The tender is explicitly not subject to EU procurement law, despite using an 'open procedure' label. Only one lot is defined, covering a single active ingredient combination. The deadline is in 2028, leaving ample time. No estimated value, award criteria, or formal eligibility requirements are provided in the notice. Procurement documents are available online.

Ryzyka

The notice explicitly states it is not a public procurement under EU directives. This may limit suppliers' legal recour...

No estimated value or budget provided. Unknown volume or pricing expectations could lead to wasted effort or unprofitab...

No procurement documents available

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Ability to supply the specified pharmaceutical product
  • Compliance with German pharmaceutical regulations (implied)

Zamawiający

Lokalizacja

Wuppertal, DEU

Identyfikator

992-80322-57

Działalność

Health

Części (1)

LOT-0000

Pharmaceutical Products – Clindamycin + Benzoylperoxide

Framework agreement for the supply of pharmaceutical products with the active ingredient combination Clindamycin and Benzoylperoxide. The agreement includes an option for additional parties to join. Duration from July 2026 to June 2028, with a possible 3-month extension. Place of performance is Wuppertal, Germany.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

Wuppertal, Germany

Czas trwania

Jun 2026 - Jun 2028

Kategoria

Pharmaceutical products

Termin

Deadline May 01, 2028

Szczegóły zamówienia

Data publikacji
18 May 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
341463-2026

Dokumenty (1)

Portal składania ofert 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3